Search research articles
Contact Us
Filters
Showing results (1-10 of 241) with videos related to
Page
of 25
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
May 29, 2003
Tuberculosis chemotherapy: still a double-edged sword
Richard E Chaisson
Antimicrobial Agents and Chemotherapy
|
September 25, 2003
Treatment of chronic infections with rifamycins: is resistance likely to follow?
Richard E Chaisson
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
September 11, 2002
TB and HIV: challenges and progress
Richard E Chaisson
The New England Journal of Medicine
|
June 20, 2020
Empirical Antituberculosis Therapy in Advanced HIV Disease - Too Much, Too Late
Richard E Chaisson
The Lancet. Infectious Diseases
|
April 25, 2014
Taking the long view on the CREATE studies' findings
Richard E Chaisson, Andrea Deluca
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2023
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
Sonya Krishnan, Richard E Chaisson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2003
Tuberculosis drug resistance: a global threat
Jean B Nachega, Richard E Chaisson
The Lancet. Global Health
|
October 14, 2017
Preventing tuberculosis in people with HIV-no more excuses
Richard E Chaisson, Jonathan E Golub
Clinics in Chest Medicine
|
May 25, 2013
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
Kerry L Dierberg, Richard E Chaisson
Tropical Medicine & International Health : TM & IH
|
November 2, 2012
A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives
Celine R Gounder, Richard E Chaisson
Page
of 25
Search research articles
Search
Showing results (1-10 of 241) with videos related to
Sort By:
Page
of 25
American Journal of Respiratory and Critical Care Medicine
|
May 29, 2003
Tuberculosis chemotherapy: still a double-edged sword
Richard E Chaisson
Antimicrobial Agents and Chemotherapy
|
September 25, 2003
Treatment of chronic infections with rifamycins: is resistance likely to follow?
Richard E Chaisson
The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
|
September 11, 2002
TB and HIV: challenges and progress
Richard E Chaisson
The New England Journal of Medicine
|
June 20, 2020
Empirical Antituberculosis Therapy in Advanced HIV Disease - Too Much, Too Late
Richard E Chaisson
The Lancet. Infectious Diseases
|
April 25, 2014
Taking the long view on the CREATE studies' findings
Richard E Chaisson, Andrea Deluca
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2023
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
Sonya Krishnan, Richard E Chaisson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2003
Tuberculosis drug resistance: a global threat
Jean B Nachega, Richard E Chaisson
The Lancet. Global Health
|
October 14, 2017
Preventing tuberculosis in people with HIV-no more excuses
Richard E Chaisson, Jonathan E Golub
Clinics in Chest Medicine
|
May 25, 2013
Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment
Kerry L Dierberg, Richard E Chaisson
Tropical Medicine & International Health : TM & IH
|
November 2, 2012
A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives
Celine R Gounder, Richard E Chaisson
Page
of 25